Retail
Subscription
to Advertise
  • ISSUES
    • 1996 to 1999
      • 1996
        • May 1996
        • June 1996
        • July 1996
        • August 1996
        • September 1996
        • October 1996
        • November 1996
        • December 1996
      • 1997
    • 2000 to 2009
      • 2006
        • January 2006
        • February 2006
        • March 2006
        • April 2006
        • May 2006
        • June 2006
        • July 2006
        • August 2006
        • September 2006
        • October 2006
        • November 2006
        • December 2006
      • 2007
        • March 2007
        • April 2007
        • May 2007
        • July 2007
        • August 2007
        • September 2007
        • November 2007
        • December 2007
      • 2008
        • January 2008
        • February 2008
        • March 2008
        • April 2008
        • May 2008
        • June 2008
        • July 2008
        • August 2008
        • September 2008
        • October 2008
        • November 2008
        • December 2008
      • 2009
        • January 2009
        • February 2009
        • March 2009
        • April 2009
        • May 2009
        • June 2009
        • June 2009
        • July 2009
        • August 2009
        • September 2009
        • October 2009
        • November 2009
        • December 2009
    • 2010 to 2019
      • 2010
        • January 2010
        • February 2010
        • March 2010
        • April 2010
        • May 2010
        • June 2010
        • July 2010
        • August 2010
        • December 2010
      • 2011
        • January 2011
        • February 2011
        • March 2011
        • April 2011
        • May 2011
        • June 2011
        • July 2011
        • August 2011
        • September 2011
        • October 2011
        • November 2011
        • December 2011
      • 2012
        • January 2012
        • February 2012
        • March 2012
        • April 2012
        • May 2012
        • June 2012
        • July 2012
        • August 2012
        • September 2012
        • October 2012
        • November 2012
        • December 2012
      • 2013
        • January 2013
        • February 2013
        • March 2013
        • April 2013
        • May 2013
        • June 2013
        • July 2013
        • August 2013
        • September 2013
        • November 2013
        • December 2013
      • 2014
        • January 2014
        • February 2014
        • March 2014
        • April 2014
        • May 2014
        • June 2014
        • July 2014
        • August 2014
        • September 2014
        • October 2014
        • November 2014
        • December 2014
      • 2015
        • January 2015
        • February 2015
        • March 2015
        • April 2015
        • May 2015
        • June 2015
        • July 2015
        • August 2015
        • September 2015
        • October 2015
        • November 2015
        • December 2015
      • 2016
        • January 2016
        • February 2016
        • March 2016
        • April 2016
        • May 2016
        • June 2016
        • July 2016
        • August 2016
        • October 2016
        • November 2016
        • December 2016
      • 2017
        • January 2017
        • February 2017
        • March 2017
        • April 2017
        • May 2017
        • June 2017
        • July 2017
        • August 2017
        • September 2017
        • October 2017
        • November 2017
        • December 2017
      • 2018
        • January 2018
        • February 2018
        • March 2018
        • April 2018
        • May 2018
        • June 2018
        • July 2018
        • August 2018
        • September 2018
        • October 2018
        • November 2018
        • December 2018
      • 2019
        • January 2019
        • February 2019
        • March 2019
        • April 2019
        • May 2019
        • June 2019
        • July 2019
        • August 2019
        • September 2019
        • October 2019
        • November 2019
        • December 2019
    • 2020 to 2023
      • 2020
        • January 2020
        • February 2020
        • March 2020
        • April 2020
        • May 2020
        • June 2020
        • July 2020
        • August 2020
        • September 2020
        • October 2020
        • November 2020
        • December 2020
      • 2021
        • January 2021
        • February 2021
        • March 2021
        • April 2021
        • May 2021
        • June 2021
        • July 2021
        • August 2021
        • September 2021
        • October 2021
        • November 2021
        • December 2021
      • 2022
        • January 2022
        • June 2022
        • February 2022
        • July 2022
        • March 2022
        • April 2022
        • August 2022
        • May 2022
        • December 2022
      • 2023
        • January 2023
        • February 2023
        • March 2023
        • July 2023
        • April 2023
        • May 2023
        • June 2023
  • FOR DIGITAL SUBSCRIPTION
  • BT AWARDS
    • BT Top 40
      • BT Top 40 2021 – 2022
    • BT Top 30
      • BT Top 30 2018 – 2019
    • BT Top 25
      • BT Top 25 2011 – 2012
      • BT Top 25 2012 – 2013
      • BT Top 25 2013 – 2014
    • BT Top 20
      • BT Top 20 2009 – 2010
      • BT Top 20 2010 – 2011
    • BT Top 10
      • BT Top 10 2008 – 2009
      • BT Top 10 2007 – 2008
      • BT Top 10 2006 – 2007
      • BT Top 10 2005 – 2006
      • BT Top 10 2003 – 2004
      • BT Top 10 2000 – 2001
      • BT Top 10 1999 – 2000
      • BT Top 10 1998 – 1999
      • BT Top 10 1997 – 1998
      • BT Top 10 1996 – 1997
      • BT Top 10 1995 – 1996
  • ABOUT US
No Result
View All Result
Business Today
No Result
View All Result

SLCPI, Enhancing The Country’S Pharmaceutical Industry

in December 2009, Featured
0

By Madhushala Senaratne | Photography by Menaka Aravinda


Since its inception in 1961, the Sri Lanka Chamber of the Pharmaceutical Industry (SLCPI) has come to form a vital segment in the local healthcare industry. Committed to protecting the interests of its members and ensuring continuous availability of a range of quality drugs, which are ethically promoted, the Chamber has grown in stature and is the voice of the pharmaceutical industry in Sri Lanka.


Ananda Samarasinghe, the current president of SLCPI spoke to us on the roles and responsibilities of the Chamber in the light of misconceptions that appears to exist about the industry.


The Chamber is involved in safeguarding the privileges and protecting the fiscal interests of the importers, manufacturers and traders, whose primary objective is to provide high quality drugs to the market at competitive prices. The Chamber which is a self-regulatory body has a strict code of ethics to ensure that its members adhere to the regulations and quality standards of ethical promotion and marketing of drugs in Sri Lanka.


Samarasinghe says, “Quality is ensured because no private sector can bring low quality products and survive in an open market.” According to Samarasinghe “Safety, efficacy and quality are three criteria that needs to be fulfilled with the Drugs Authority of Sri Lanka to be entitled to import a drug to the country. To satisfy these, there’s a lot of authentic documentation required. The drug authority takes a lot of effort to evaluate such files, he stated.


“Like any other profession or occupation, we have in our industry, miscreants who resort to shortcuts without following the set rules and procedures. But our members should not be judged by those illegal miscreants as all our members are firmly committed to the ethics of our industry mentioned above,” he added.


The Chamber Members liaises with the Government in the procurement of drugs required by the Ministry of Health. Samarasinghe says, “These two excellent systems – Government’s island-wide free healthcare system and the private sector healthcare system offers patients the freedom of choice of either system. It is the end result of these two systems which have contributed to the best health index in our country, in par or even above any developed world.”


The topic of advertising drugs in the media is not commonly discussed. Samarasinghe says, “Drugs need to be promoted but it is an accepted norm that we cannot use the media to address or publish drugs. So we use personnel promotion.” He adds, “the main responsibility of a promoter of a drug, called the Medical Representative is to take important messages, with the relevant clinical data and samples, of his product to the doctor so that a doctor uses his professional skills to decide the best from the array of such different products offered, for his patient.”


The SLCPI and its members are aware of the need for medical assistance amongst the masses and the burden laid on the Government in sustaining a free healthcare system. In this regard, the Chamber has facilitated a number of CSR projects including free medical camps and clinics. They have also rendered support to the Government in large measures during the post tsunami period and currently aiding the IDPs.


Talking about the future plans of the Chamber he says, “We have helped the Government to run diabetic clinics in a number of centres through which diabetic centres have been established. We have initiated encouraging professional training of medical representatives to implement the code of ethics and ethical promotion of pharmaceuticals.”


“Our future plans are to continue doing projects that will support the society and that will enhance the pharmaceutical industry further,” he concluded.

Business Today August 2023

Business Today September 2023

  • Privacy Policy
  • Terms & Conditions

© 2023 BT Options. All Rights Reserved

No Result
View All Result
  • ISSUES
    • 1996 to 1999
      • 1996
      • 1997
    • 2000 to 2009
      • 2006
      • 2007
      • 2008
      • 2009
    • 2010 to 2019
      • 2010
      • 2011
      • 2012
      • 2013
      • 2014
      • 2015
      • 2016
      • 2017
      • 2018
      • 2019
    • 2020 to 2023
      • 2020
      • 2021
      • 2022
      • 2023
  • FOR DIGITAL SUBSCRIPTION
  • BT AWARDS
    • BT Top 40
      • BT Top 40 2021 – 2022
    • BT Top 30
      • BT Top 30 2018 – 2019
    • BT Top 25
      • BT Top 25 2011 – 2012
      • BT Top 25 2012 – 2013
      • BT Top 25 2013 – 2014
    • BT Top 20
      • BT Top 20 2009 – 2010
      • BT Top 20 2010 – 2011
    • BT Top 10
      • BT Top 10 2008 – 2009
      • BT Top 10 2007 – 2008
      • BT Top 10 2006 – 2007
      • BT Top 10 2005 – 2006
      • BT Top 10 2003 – 2004
      • BT Top 10 2000 – 2001
      • BT Top 10 1999 – 2000
      • BT Top 10 1998 – 1999
      • BT Top 10 1997 – 1998
      • BT Top 10 1996 – 1997
      • BT Top 10 1995 – 1996
  • ABOUT US

© 2023 BT Options. All Rights Reserved